Spectroscopic characterization of eupalitin-3-O-β-D-galactopyranoside from Boerhavia procumbens: In vivo hepato-protective potential in rat model

Abdul Wajid Khalil,Zafar Iqbal,Achyut Adhikari,Hamayun Khan,Umar Nishan,Anwar Iqbal,Javed Abbas Bangash,Omer Mukhtar Tarar,Ahmad Bilal,Shahid Ali Khan,Daniel C Hoessli,Mohammed A Assiri,Zhiyuan Wu,Saifullah Afridi,Daniel C. Hoessli,Mohammed A. Assiri
DOI: https://doi.org/10.1016/j.saa.2023.123369
2024-01-01
Abstract:The liver is one of the most important organs responsible for detoxifying biomolecules and xenobiotics. Herein, we report the isolation, characterization, and hepatoprotective effect of the Boerhavia procumbens-derived eupalitin-3-O-β-D-galactopyranoside (EGP) compound. The structure of the EGP compound was deduced by using NMR spectroscopic techniques and mass spectrometry. The EGP hepatoprotective activities were evaluated with HepG2 cell viability and LDH assays in vitro, and CCl<sub>4</sub>-induced toxicity was investigated in vivo in the rat model. Compared to the CCl<sub>4</sub>-treated group, cells exposed to the EGP compound at 200 µg/ml showed increased cell viability (60.52 ± 1.22 %) and decreased LDH levels (23.81 ± 1.89 U/ml). The serum levels of SGPT, SGOT, ALP, and total bilirubin in the CCl4-treated group were substantially higher than those in the control group (64 ± 1.89 U/ml, 86 ± 1.47 U/ml, 252.6 ± 2.96 U/ml, and 5.45 ± 0.32 mg/dl, respectively). When compared to animals treated with CCl<sub>4</sub> alone, the EGP compound's in vivo hepatoprotective effect at 60 mg/kg with CCl<sub>4</sub> significantly (p &lt; 0.01) decreased the levels of SGPT and SGOT (26 ± 1.34 U/ml and 42.92 ± 1.6 U/ml) respectively. Furthermore, our histological study showed a significant response in restoring and maintaining the normal morphological appearance of the liver. Thus, our results show that the EGP compound is a promising and novel lead molecule for better hepatotoxicity control and therapy.
spectroscopy
What problem does this paper attempt to address?